OEM Medical Devices, Medical Device Assembly, Medical Equipment, Contract Manufacturer

What's New / Current Events

NEXCORE Technology Cited for Work on Two Award-Winning Products
Therapeutic Hypothermia System Moved at Red Hot Rate
City Pushes Cooling Therapy for Cardiac Arrest - New York Times
Life Recovery Systems Receives NIH Grant
FDA Approves Testing of Rapid Patient Cooling for Brain Injuries
Milton Frank Appoints COO of Life Recovery Systems
NEXCORE Selected to Manufacture Endoscopic Cryotherapy Device
NEXCORE Speeds Polar Wand to Market Frost and Sullivan, Medical Devices Technology Alert
NEXCORE, GI Supply Agree on Endoscopic Cryotherapy Device

NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System

Waldwick, NJ, Jan. 14, 2008 – NEXCORE Technology, Inc, a world-class original equipment manufacturer (OEM) of medical devices, has licensed all the intellectual property rights for the development of a major advance in fluid management during endoscopic surgery. The new system provides significantly greater control over the inflo/outflow of fluids during a procedure.

The patents on the system are held by Drs. Atul and Alka Kumar. Dr. Atul Kumar, a pioneer in hysteroscopic surgery, is scientific director of the Women’s Health Center in Jaipur, India. Dr. Alka Kumar is the director of the Women’s Health Center.

NEXCORE is designing and developing the new system and will organize testing and FDA approval.

According to Milton Frank, President and CEO of NEXCORE, “The new system maintains a constant preset cavity pressure during operations regardless of how the flow rate of the irrigational fluid is varied allowing for optimal visualization. The system measures the intravasation rate and total fluid intravasation.” Intravasation is fluid that is absorbed into the blood vessels during a procedure which can cause severe injury, or even death, if not properly monitored.

The new system can be used in any endoscopic surgery. It distends the body tissue cavity by utilizing continuous flow irrigation. The new invention increases surgical efficiency, effectiveness and safety by maintaining a constant pressure on the mechanical distension of the cavity and increases and maintains visibility for the surgeon.

Features unique to the new system include:

The fluid pressure is independent of the flow rate and the desired cavity pressure and distention can be maintained for an indefinite time. A clinical study published in 2004 reported that endometrial resections were performed on 539 women using the new system without any complications because of the system’s predictably stable mechanical distention.
Predictably constant and clear visualization is present throughout the procedure. Only negligible or minimal fluid turbulence is present inside the cavity even at relatively high flow rates.
The real-time rate of intravasation is known throughout the procedure thwarting fluid intravasation, or fluid overload, a dangerous complication in procedures such as trans urethral surgery and hysteroscopic surgery. In current systems, the fluid absorbed in the patient’s body is determined by subtracting the waste fluid from the sterile fluid. In the new system, the instantaneous introduction of fluid into the blood stream can be determined without any fluid sensors and the surgeon can act within seconds.
It is possible to safely, easily and quickly switch between two different types of irrigation fluid. NEXCORE plans to introduce the system in late 2008.

NEXCORE Technology Moves to New Headquarters
Medical Device Manufacturer Triples Space

WALDWICK, NJ, Oct. 10 – NEXCORE Technology, Inc., a world-class original equipment manufacturer (OEM) of medical devices, has moved to larger headquarters in a stand-alone building in Waldwick, NJ.

The 30,000-square-foot facility at 150 Hopper Avenue is FDA GMP compliant and certified ISO 13485:2003 and ISO 9001:2000 and triples the company’s previous space in Hackensack, NJ.

“Our business has been growing and the new facility gives NEXCORE the capability to quadruple the products we develop and manufacture and also provides us with the option of further expansion,” said Milton Frank, founder, president and CEO of NEXCORE.

The new facility has the capability to manufacture surface mount printed circuit boards and triples the R&D space and capabilities. Additionally, the four controlled assembly areas are suitable for the manufacturing of sterile products.

NEXCORE Technology is a world-class OEM medical device manufacturer specializing in complex diagnostic and therapeutic systems. It produces some of the industries most innovative products for numerous large and sophisticated medical device manufacturers, taking the specifications from concept through design and manufacturing to after-market services.